Correlation Between Innate Pharma and Alpha Tau

Can any of the company-specific risk be diversified away by investing in both Innate Pharma and Alpha Tau at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innate Pharma and Alpha Tau into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Innate Pharma and Alpha Tau Medical, you can compare the effects of market volatilities on Innate Pharma and Alpha Tau and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innate Pharma with a short position of Alpha Tau. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innate Pharma and Alpha Tau.

Diversification Opportunities for Innate Pharma and Alpha Tau

0.33

Correlation Coefficient

Innate Pharma  Alpha Tau

Weak diversification

The 3 months correlation between Innate and Alpha is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Innate Pharma and Alpha Tau Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alpha Tau Medical and Innate Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innate Pharma are associated (or correlated) with Alpha Tau. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alpha Tau Medical has no effect on the direction of Innate Pharma i.e., Innate Pharma and Alpha Tau go up and down completely randomly.

Pair Corralation between Innate Pharma and Alpha Tau

Given the investment horizon of 90 days Innate Pharma is expected to generate 12.09 times less return on investment than Alpha Tau. But when comparing it to its historical volatility, Innate Pharma is 3.5 times less risky than Alpha Tau. It trades about 0.03 of its potential returns per unit of risk. Alpha Tau Medical is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  22.00  in Alpha Tau Medical on December 28, 2024 and sell it today you would earn a total of  1.00  from holding Alpha Tau Medical or generate 4.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	78.33%
Values	Daily Returns

Innate Pharma  vs.  Alpha Tau Medical

Innate Pharma

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Innate Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating technical indicators, Innate Pharma may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Alpha Tau Medical

Risk-Adjusted Performance

OK

Over the last 90 days Alpha Tau Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly uncertain basic indicators, Alpha Tau showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Innate Pharma and Alpha Tau

The main advantage of trading using opposite Innate Pharma and Alpha Tau positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innate Pharma position performs unexpectedly, Alpha Tau can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alpha Tau will offset losses from the drop in Alpha Tau's long position.

The idea behind Innate Pharma and Alpha Tau Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.